{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:16:35Z","timestamp":1781842595281,"version":"3.54.5"},"reference-count":12,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1183\/23120541.00724-2023","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:30:54Z","timestamp":1700159454000},"page":"00724-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey"],"prefix":"10.1183","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-3398","authenticated-orcid":false,"given":"Michal","family":"Shteinberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3442-4739","authenticated-orcid":false,"given":"Arietta","family":"Spinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Goeminne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Crichton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"2024101712102300000_10.1.00724-2023.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024101712102300000_10.1.00724-2023.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2024101712102300000_10.1.00724-2023.3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101712102300000_10.1.00724-2023.4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s13063-019-3766-9","article-title":"A 2\u00d72 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52\u2009weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial","volume":"20","author":"Bradley","year":"2019","journal-title":"Trials"},{"key":"2024101712102300000_10.1.00724-2023.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00220001"},{"key":"2024101712102300000_10.1.00724-2023.6","doi-asserted-by":"crossref","first-page":"101045","DOI":"10.1016\/j.conctc.2022.101045","article-title":"The BATTLE study: effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol","volume":"30","author":"Terpstra","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"key":"2024101712102300000_10.1.00724-2023.7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","article-title":"A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection","volume":"163","author":"Guan","year":"2023","journal-title":"Chest"},{"key":"2024101712102300000_10.1.00724-2023.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"2024101712102300000_10.1.00724-2023.9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024101712102300000_10.1.00724-2023.10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2024101712102300000_10.1.00724-2023.11","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2022.220292R2"},{"key":"2024101712102300000_10.1.00724-2023.12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/antibiotics12020267","article-title":"How to use nebulized antibiotics in severe respiratory infections","volume":"12","author":"Gorham","year":"2023","journal-title":"Antibiotics (Basel)"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00724-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:30:37Z","timestamp":1740375037000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00724-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,15]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1183\/23120541.00724-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00724-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}